Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
Recruiting
SONATA: Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adults with medication-refractory focal epilepsy who have undergone RNS implantation at least six months prior and are in the judgement of the treating physician on a stable RNS regimen in terms of stimulation * Willing to attend all study visits and complete all required study procedures * Access to private or public wireless data service at regular intervals * Access to personal mobile device Exclusion Criteria: * Documentation of a musicogenic, or auditory-triggered focal seizure semiology * Participant is unable to reasonably participate in study tasks as determined by the investigator * Inability to obtain informed consent from the patient or legally authorized representative
About the study
This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.
What is being tested
- Experimental Intervention (Music A) (other)
- Active Comparator Intervention (Music B) (other)
- Active Comparator Intervention (Music C) (other)
Sponsor: Dartmouth-Hitchcock Medical Center · Participants: 24 · Started: Jul 22, 2025
Contact the study team
- Anastasia Kanishcheva, MPH · Phone: 603-650-0260
- Brian C Fidali, MD · Phone: 603-650-5104
Official record on ClinicalTrials.gov — NCT06425029
Locations in the U.S.
| Massachusetts | University of Massachusetts Chan Medical School, Worcester (Not yet recruiting) |
| New Hampshire | Dartmouth-Hitchcock Medical Center, Lebanon |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.